中文 
别名:PKI-beta; cAMP-dependent protein kinase inhibitor beta; PKIB; PRKACN2;应用:IHC,ICC
反应种属:Human
规格：50μl/100μl
| Description |
|---|
| Extremely potent competitive inhibitor of cAMP-dependent protein kinase activity, this protein interacts with the catalytic subunit of the enzyme after the cAMP-induced dissociation of its regulatory chains By similarity.Zheng L., Biochem. J. 349:403-407(2000).Mungall A.J., Nature 425:805-811(2003).The MGC Project Team, Genome Res. 14:2121-2127(2004). |
| Specification | |
|---|---|
| Aliases | PKI-beta; cAMP-dependent protein kinase inhibitor beta; PKIB; PRKACN2; |
| Entrez GeneID | 5570; |
| Swissprot | Q9C010 |
| WB Predicted band size | 8kDa |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human |
| Immunogen | Synthesized peptide derived from internal of human IPKB. |
| Formulation | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Application | |
|---|---|
| IHC | 1/50-1/100 |
| ICC | 1/100-1/500 |
 |
Immunofluorescence analysis of MCF-7 cells, using IPKB antibody P42102. |
 |
Immunohistochemistry analysis of paraffin-embedded human brain tissue, using IPKB antibody P42102. |
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
暂无评论
本公司的所有产品仅用于科学研究或者工业应用等非医疗目的，不可用于人类或动物的临床诊断或治疗，非药用，非食用。
发表回复